Van Eyk, Dunn - Proteomic and Genomic Analysis of Cardiovascular Disease - 2003 (522919), страница 98
Текст из файла (страница 98)
M., Elghannam, H., Gotto, A. M., Jr., Marian, A. J. 2001. Novel polymorphisms inpromoter region of atp binding cassettetransporter gene and plasma lipids, severity, progression, and regression of coronary atherosclerosis and response totherapy. Circ. Res. 88:969–973.Clee, S. M., et al.
2000. Age and residualcholesterol efflux affect HDL cholesterollevels and coronary artery disease inABCA1 heterozygotes. J. Clin. Invest.106:1263–1270.Cavelier, L. B., et al. 2001. Regulationand activity of the human ABCA1 genein transgenic mice. J. Biol. Chem.276:18 046–18 051.Joyce, C. W., et al.
2002. The ATP binding cassette transporter A1 (ABCA1)modulates the development of aorticatherosclerosis in C57BL/6 and apoEknockout mice. Proc. Natl. Acad. Sci.USA 99:407–412.Vaisman, B. L., et al. 2001. ABCA1 overexpression leads to hyperalphalipoproteinemia and increased biliary cholesterolexcretion in transgenic mice. J. Clin. Invest. 108:303–309.Singaraja, R. R., et al.
2001. HumanABCA1 BAC transgenic mice show increased high density lipoprotein cholesterol and ApoAI-dependent efflux stimulated by an internal promoter containingliver X receptor response elements in intron 1. J. Biol. Chem. 276:33 969–33 979.Orso, E., et al. 2000. Transport of lipidsfrom golgi to plasma membrane is defec-35535620 Genomics Perspective for Drug Discovery43444546474849505152tive in tangier disease patients and Abc1deficient mice.
Nat. Genet. 24:192–196.McNeish, J., et al. 2000. High density lipoprotein deficiency and foam cell accumulation in mice with targeted disruptionof ATP-binding cassette transporter-1.Proc. Natl. Acad. Sci. USA 97:4245–4250.Yokoyama, S., Kurasawa, T., Nishikawa,O., Yamamoto, A. 1986.
High density lipoproteins with poor reactivity to cholesteryl ester transfer reaction observed in ahomozygote of familial hyperalphalipoproteinemia. Artery 14:43–51.Kurasawa, T., Yokoyama, S., Miyake, Y.,Yamamura, T., Yamamoto, A. 1985. Rateof cholesteryl ester transfer between highand low density lipoproteins in humanserum and a case with decreased transferrate in association with hyperalphalipoproteinemia. J. Biochem. (Tokyo)98:1499–1508.Drayna, D., et al. 1987. Cloning and sequencing of human cholesteryl estertransfer protein cDNA. Nature 327:632–634.Herrera, V. L., et al.
1999. Spontaneouscombined hyperlipidemia, coronary heartdisease and decreased survival in Dahlsalt-sensitive hypertensive rats transgenicfor human cholesteryl ester transfer protein. Nat. Med. 5 :1383–1389.Inazu, A., et al. 1994. Genetic cholesterylester transfer protein deficiency causedby two prevalent mutations as a majordeterminant of increased levels of highdensity lipoprotein cholesterol. J. Clin.Invest 94:1872–1882.Okamoto, H., et al. 2000.
A cholesterylester transfer protein inhibitor attenuatesatherosclerosis in rabbits. Nature406:203–207.Kogushi, M., et al. 1996. Anti-atherosclerotic effect of E5324, an inhibitor of acylCoA:cholesterol acyltransferase, in Watanabe heritable hyperlipidemic rabbits.Atherosclerosis 124:203–210.Hoeg, J.
M., et al. 1996. Overexpressionof lecithin:cholesterol acyltransferase intransgenic rabbits prevents diet-inducedatherosclerosis. Proc. Natl. Acad. Sci.USA 93:11 448–11 453.Chao, J., Chao, L. 1996. Functional analysis of human tissue kallikrein in trans-5354555657585960616263genic mouse models. Hypertension27:491–494.Wang, C., Chao, L., Chao, J. 1995. Direct gene delivery of human tissue kallikrein reduces blood pressure in spontaneously hypertensive rats.
J. Clin. Invest.95:1710–1716.Yayama, K., Wang, C., Chao, L., Chao,J. 1998. Kallikrein gene delivery attenuates hypertension and cardiac hypertrophy and enhances renal function inGoldblatt hypertensive rats. Hypertension31:1104–1110.Kim, H. S., et al. 1995. Genetic control ofblood pressure and the angiotensinogenlocus. Proc. Natl.
Acad. Sci. USA92:2735–2739.Makino, N., Sugano, M., Ohtsuka, S.,Sawada, S., Hata, T. 1999. Chronic antisense therapy for angiotensinogen oncardiac hypertrophy in spontaneously hypertensive rats. Cardiovasc. Res 44:543–548.Tang, X., et al. 1999. Intravenous angiotensinogen antisense in AAV-based vector decreases hypertension. Am.J. Physiol.277:H2392–H2399.Tomita, N., et al.
1995. Transient decrease in high blood pressure by in vivotransfer of antisense oligodeoxynucleotides against rat angiotensinogen. Hypertension 26:131–136.Krege, J. H., et al. 1995. Male-female differences in fertility and blood pressure inACE-deficient mice. Nature 375:146–148.Esther, C. R., Jr., et al. 1996. Mice lacking angiotensin-converting enzyme havelow blood pressure, renal pathology, andreduced male fertility. Lab.
Invest.74:953–965.Freedman, N. J., et al. 1995. Phosphorylation and desensitization of the humanbeta 1-adrenergic receptor. Involvementof G protein-coupled receptor kinasesand cAMP-dependent protein kinase. J.Biol. Chem. 270:17 953–17 961.Koch, W. J., et al. 1995.
Cardiac functionin mice overexpressing the beta-adrenergic receptor kinase or a beta ARK inhibitor. Science 268:1350–1353.Harding, V. B., Jones, L. R., Lefkowitz,R. J., Koch, W. J., Rockman, H. A. 2001.Cardiac beta ARK1 inhibition prolongs20.5 References64656667686970717273survival and augments beta blocker therapy in a mouse model of severe heartfailure. Proc. Natl. Acad. Sci. USA98:5809–5814.Li, Y., Love, M. L., Putkey, J. A., Cohen,C. 2000. Bepridil opens the regulatory Nterminal lobe of cardiac troponin C.
Proc.Natl. Acad. Sci. USA 97:5140–5145.Rayment, I., Holden, H. M., Sellers,J. R., Fananapazir, L., Epstein, N. D.1995. Structural interpretation of the mutations in the beta-cardiac myosin thathave been implicated in familial hypertrophic cardiomyopathy. Proc. Natl. Acad.Sci. USA 92:3864–3868.Deivanayagam, C. C., Carson, M., Thotakura, A., Narayana, S. V., Chodavarapu, R. S. 2000. Structure of FKBP12.6 incomplex with rapamycin.
Acta. Crystallogr.D. Biol. Crystallogr. 56 (Pt 3):266–271.Morais Cabral, J. H., et al. 1998. Crystalstructure and functional analysis of theHERG potassium channel N terminus: aeukaryotic PAS domain. Cell. 95:649–655.Hayakawa, K., et al. 1994. Crystallizationof canine cardiac calsequestrin. J. Mol.Biol. 235:357–360.Tomizaki, T., et al. 1999. Structure analysis of bovine heart cytochrome c oxidaseat 2.8 A resolution. Acta. Crystallogr. D.Biol. Crystallogr. 55 (Pt 1):31–45.Taylor, P., Bilsland, M., Walkinshaw,M. D. 2001. A new conformation of theintegrin-binding fragment of humanVCAM-1 crystallizes in a highly hydratedpacking arrangement. Acta. Crystallogr.
D.Biol. Crystallogr. 57:1579–1583.Janosik, M., et al. 2001. Crystallizationand preliminary X-ray diffraction analysisof the active core of human recombinantcystathionine beta-synthase: an enzymeinvolved in vascular disease. Acta. Crystallogr. D. Biol. Crystallogr. 57:289–291.van den, A. F., et al.
2000. Structure ofthe dimerized hormone-binding domainof a guanylyl-cyclase-coupled receptor.Nature 406:101–104.Casasnovas, J. M., Stehle, T., Liu, J. H.,Wang, J. H., Springer, T. A. 1998. A dimeric crystal structure for the N-terminaltwo domains of intercellular adhesionmolecule-1. Proc. Natl. Acad. Sci. USA95:4134–4139.7475767778798081828384Wiesmann, C., et al.
1997. Crystal structure at 1.7 A resolution of VEGF in complex with domain 2 of the Flt-1 receptor.Cell. 91:695–704.Istvan, E. S., Deisenhofer, J. 2001.Structural mechanism for statin inhibition of HMG-CoA reductase. Science292:1160–1164.Langer-Safer, P. R., et al. 1991. Replacement of finger and growth factor domains of tissue plasminogen activatorwith plasminogen kringle 1. Biochemicaland pharmacological characterization ofa novel chimera containing a high affinity fibrin-binding domain linked to a heterologous protein.
J. Biol. Chem.266:3715–3723.Keyt, B. A., et al. 1994. A faster-actingand more potent form of tissue plasminogen activator. Proc. Natl. Acad. Sci.USA 91:3670–3674.Reed, G. L., et al. 1999. A catalytic switchand the conversion of streptokinase to afibrin-targeted plasminogen activator.Proc. Natl. Acad.
Sci. USA 96:8879–8883.Hughes, R. E., et al. 2001. Altered transcription in yeast expressing expandedpolyglutamine. Proc. Natl. Acad. Sci. USA98:13 201–13 206.Plump, A. S., et al. 1992. Severe hypercholesterolemia and atherosclerosis inapolipoprotein E-deficient mice createdby homologous recombination in EScells. Cell. 71:343–353.Zhang, S. H., Reddick, R.
L., Piedrahita, J. A., Maeda, N. 1992. Spontaneoushypercholesterolemia and arterial lesionsin mice lacking apolipoprotein E. Science258:468–471.Merkel, M., Velez-Carrasco, W., Hudgins, L. C., Breslow, J. L. 2001. Compared with saturated fatty acids, dietarymonounsaturated fatty acids and carbohydrates increase atherosclerosis andVLDL cholesterol levels in LDL receptordeficient, but not apolipoprotein E-deficient, mice. Proc. Natl.
Acad. Sci. USA98:13 294–13 299.Roden, D. M., George, A. L. Jr. 2002.The genetic basis of variability in drugresponses. Nature Reviews 1:37–44.Marian, A. J. 2001. On genetics, inflammation, and abdominal aortic aneurysm:35735820 Genomics Perspective for Drug Discovery8586878889can single nucleotide polymorphismspredict the outcome? Circulation103:2222–2224.Aithal, G. P., Day, C. P., Kesteven, P. J.,Daly, A. K. 1999.
Association of polymorphisms in the cytochrome P450CYP2C9 with warfarin dose requirementand risk of bleeding complications. Lancet 353:717–719.Koytchev, R., et al. 1998. Influence ofthe cytochrome P4502D6*4 allele on thepharmacokinetics of controlled-releasemetoprolol. Eur. J. Clin. Pharmacol.54:469–474.Kuivenhoven, J. A., et al. 1998. The roleof a common variant of the cholesterylester transfer protein gene in the progression of coronary atherosclerosis.
TheRegression Growth Evaluation StatinStudy Group. N. Engl. J. Med. 338:86–93.Ueda, S., Meredith, P. A., Morton, J. J.,Connell, J. M., Elliott, H. L. 1998. ACE(I/D) genotype as a predictor of the magnitude and duration of the response toan ACE inhibitor drug (enalaprilat) inhumans. Circulation 98:2148–2153.Mitcheson, J. S., Chen, J., Lin, M., Culberson, C., Sanguinetti, M. C. 2000. Astructural basis for drug-induced long9091929394QT syndrome.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
